[ Cue raises $15.5M in Series B ]
Cue has raised $15.5 million in Series B funding.
Founded in 2010, Cue develops a consumer health device that allows users to track testosterone, influenza, fertility and vitamin D levels via smartphone.
For the first time, consumers can track 5 key health and lifestyle indicators: inflammation, vitamin D, fertility, influenza, and testosterone in just minutes, at home. Cue sends the data via Bluetooth 4.0 to the user’s smartphone, where the free Cue app reveals the interplay of activity, food, and sleep shaping the user at a molecular level.
|City||San Diego, California|
|Founder / CEO||Mr. Ayub Khattak|
|Previous Investors||Dentsu Ventures|